从提供的文献中，我们可以提取出与遗传变异、疾病和实验方法相关的信息，并将其结构化为JSON格式。以下是提取和标准化后的信息：

### 提取的JSON格式信息

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.89A>G",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "G",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "N",
                        "alt": "S",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutation in SNCA"
                },
                {
                    "HGVS": "NM_000345.4:c.158A>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "C",
                        "position": "158"
                    },
                    "Protein Change": {
                        "ref": "T",
                        "alt": "A",
                        "position": "53"
                    },
                    "Description in input context": "A53T mutation in SNCA"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's Disease",
        "MONDO": "MONDO:0005072"
    },
    "Experiment Method": [
        {
            "Assay Method": "Isothermal Titration Calorimetry (ITC)",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Recombinant human α-synuclein (WT, A30P, A53T)",
                "Description": "Recombinant human α-synuclein (WT, A30P, A53T) proteins were provided by Dr. Peter T. Lansbury (Harvard University)."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "The binding constant for A30P is slightly lower (30% lower) than that of WT and A53T under the same conditions. A30P exhibits two types of binding to Cu(II), with a minor but strong binding site (10^10 M^-1) attributed to the binding to small oligomeric species."
                },
                {
                    "Variant": "NM_000345.4:c.158A>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "The binding constants for Cu(II) to WT and A53T are similar, both ~2.4 × 10^9 and ~4.8 × 10^9 M^-1 at pH 7.2 and 7.4, respectively."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Two runs for each condition were performed, and the deviations of the fitted results were within 10%."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was titrated twice."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT α-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "No",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "No",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Nonlinear least-squares fit of the ITC data was used to determine the binding parameters."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Binding stoichiometry of 0.7-0.9:1 for all proteins studied.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Binding stoichiometry outside the range of 0.7-0.9:1.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释

1. **Variants Include**:
   - 文献中提到的两个突变分别是`A30P`和`A53T`，它们位于`SNCA`基因上。
   - `A30P`突变导致了氨基酸位置30处的天冬酰胺（N）被脯氨酸（P）替代。
   - `A53T`突变导致了氨基酸位置53处的苏氨酸（T）被丙氨酸（A）替代。

2. **Described Disease**:
   - 研究的疾病是帕金森病（Parkinson's Disease），对应的MONDO术语为`MONDO:0005072`。

3. **Experiment Method**:
   - 实验方法是等温滴定量热法（ITC）。
   - 使用的材料来源是重组蛋白，具体为重组人类α-突触核蛋白（WT, A30P, A53T），由哈佛大学的Peter T. Lansbury博士提供。
   - 结果读出类型为定量。
   - 对于每个实验方法，读出描述包括所有提到的变异及其结论和分子效应。
   - 进行了生物学重复实验，每次条件进行了两次运行，结果偏差在10%以内。
   - 进行了技术重复实验，每个样本滴定两次。
   - 设置了基本阳性对照，使用野生型α-突触核蛋白作为阳性对照。
   - 没有设置基本阴性对照。
   - 没有包括验证控制（无论是致病性还是良性变异）。
   - 统计分析方法是非线性最小二乘拟合ITC数据以确定结合参数。
   - 正常读出阈值为所有研究蛋白质的结合化学计量比为0.7-0.9:1。
   - 异常读出阈值为结合化学计量比超出0.7-0.9:1的范围。
   - 该实验方法通常用于研究这种疾病。

通过这种方式，我们可以确保提取的信息准确且符合科学文献的标准。